Skip to main content

Find Clinical Trials

Home
Conditions
Fibrosis

Clinical trial condition

Fibrosis

Explore clinical trials studying Fibrosis. Study availability and eligibility vary by location and protocol.

1,524 public trials 286 recruiting studies

Refine in advanced search Browse all conditions

Fibrosis trial results

Completed

Evaluation of Bioresorbable Sheet to Prevent Intra-Abdominal Adhesions in Colorectal Surgeries

NCT00902148

Conditions: Adhesions, Cicatrix, Fibrosis, +3 more
Locations: Akershus University Hospital Lørenskog, Oslo, Norway

View Trial Details

Completed

Evaluation of the PK of NRL972 Following Pre- and co-Administration of Ursodeoxycholic Acid and Cloxacillin

NCT00857480

Conditions: Digestive System Diseases, Fibrosis, Hepatic Cirrhosis, +4 more
Locations: MHAPT "Zarita Johanna" University Hospital Sofia, Bulgaria

View Trial Details

Completed

Clearance of NRL972 in Patients With Cirrhosis and in Healthy Volunteers

NCT00856713

Conditions: Digestive System Diseases, Fibrosis, Hepatic Cirrhosis, +4 more
Locations: UMHAPT St Ivan Rilski's University Hospital Sofia, Bulgaria

View Trial Details

Completed

Clearance of NRL972 in Patients With Cirrhosis, Nonalcoholic Steatohepatitis (NASH) and in Healthy Volunteers

NCT00856869

Conditions: Digestive System Diseases, Fatty Liver, Fibrosis, +7 more
Locations: UMHAPT St. Ivan Rilski's University Hospital Sofia, Bulgaria

View Trial Details

Completed

Safety and Efficacy of RN1001(Avotermin) in Healthy Male Subjects

NCT00847925

Conditions: Cicatrix, Fibrosis, Pathologic Processes, +1 more
Locations: Renovo CTU Manchester, United Kingdom

View Trial Details

Completed

Efficacy and Safety of Intradermal RN1001 (Avotermin) in Elderly Subjects.

NCT00847795

Conditions: Cicatrix, Fibrosis, Pathologic Processes, +1 more
Locations: Renovo CTU Manchester, United Kingdom

View Trial Details

Completed

Safety and Efficacy of Long-Term Treatment With Atorvastatin in Patients With Primary Biliary Cirrhosis

NCT00844402

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +20 more
Locations: Department of Internal Medicine, Medical University of Graz Graz, Austria

View Trial Details

Completed

Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic Ascites

NCT00501722

Conditions: Ascites, Digestive System Diseases, Fibrosis, +8 more
Locations: Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States

Sanofi-Aventis Administrative Office Buenos Aires, Argentina

Sanofi-Aventis Administrative Office Cove, New South Wales, Australia

Sanofi-Aventis Administrative Office Diegem, Belgium

View all 13 locations

View Trial Details

Completed

Satavaptan Dose-Ranging Study in the Prevention of Ascites

NCT00501384

Conditions: Ascites, Digestive System Diseases, Fibrosis, +4 more
Locations: Sanofi-Aventis Administrative Office Buenos Aires, Argentina

Sanofi-Aventis Administrative Office Cove, New South Wales, Australia

Sanofi-Aventis Administrative Office Diegem, Belgium

Sanofi-Aventis Administrative Office Laval, Quebec, Canada

View Trial Details

Completed

Prevention of Bleeding in Patient With Cirrhosis Undergoing Dental Extraction

NCT00816127

Conditions: Cardiovascular Diseases, Coagulopathy, Digestive System Diseases, +10 more
Locations: Mount Sinai School of Medicine New York, United States

View Trial Details